A Tipping Point: Organ Shortages and the Future of Transplantation
Increasingly, more patients qualify for transplants, making organ shortages today’s most pressing issue.
Navigating the New Era of Organ Transplantation: Key Areas of Success
As a heart transplant recipient less than three years out from quadruple organ failure, and a father of two young children, I'm not just hoping that modernization will save and extend more lives. I'm counting on it.
presented by
The 5 Best Medical Billing Outsourcing Companies
Medical billing is a tedious administrative task, but outsourcing it may be the key to increased revenue. Explore the top medical billing outsourcing companies and the benefits of partnering with one.
INVEST Pitch Perfect Spotlight: How OmniLife Health Is Streamlining Organ Transplants
OmniLIfe Health, based in Lexington, Kentucky, won the MedCity News INVEST Pitch Perfect contest on May 23, beating five other payer/provider startups. The company works to streamline workflows for organ transplants.
Organ Preservation Company Rakes In $24M to Expand Commercial Footprint
Paragonix Technologies recently closed a $24 million Series B funding round. The Cambridge, Massachusetts-based company provides transplant centers and organ procurement organizations with medical devices designed for the preservation and transportation of donor organs.
Cell therapy biotech Quell adds $156M for alternative to organ transplant meds
Quell Therapeutics' $156 million Series B round comes as it prepares to advance to a clinical trial testing its lead regulatory T cell therapy candidate as way to prevent organ rejection in liver transplant patients. The progress is part of a growing field of Treg cell therapy developers that is becoming increasingly competitive.
FDA hands out approvals to Takeda transplant drug, Aadi Bio cancer therapy
Takeda Pharmaceutical won FDA approval for Livtencity, an antiviral developed to treat cytomegalovirus infection in transplant patients. The agency also approved an Aadi Biosciences drug, making it the first therapy authorized for treating a rare type of soft-tissue cancer.
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.
Novartis “one transplant for life” drug flunks test in kidney transplant patients
A Novartis drug intended to prevent organ rejection has failed to beat out the standard of care therapy in a Phase 2 study in kidney transplant patients. Other clinical trial failures announced ahead of the Labor Day weekend include a Forte Biosciences atopic dermatitis drug, as well a cancer therapy from Takeda Pharmaceutical.
Talaris Therapeutics’ IPO raises $150M to transform solid organ transplants
Three biotechs IPOs priced this week while one gene therapy developer postponed its plans. The biggest IPO belongs to Talaris Therapeutics, a company developing a cell therapy for organ transplant patients that could mean the end of lifelong immunosuppressive drugs that prevent rejection.
TransMedics raises $20M for “living organ transplant” device
The standard for organ transplant is a plastic picnic cooler filled with ice. Boston-based TransMedics is one-upping this idea with a warm blood perfusion device - essentially keeping organs alive as they await transplant surgery.
Organs from a deceased newborn successfully transplanted in two patients for the first time in Britain
A 6.6 pound baby girl sadly suffered irreparable brain damage in the womb, but for the first time in Britain, surgeons were able to transplant her kidneys, which were transplanted into a patient with renal failure, and liver cells, which were donated to a second recipient who had liver damage. Doctors tried to revive the […]
presented by
The 3 Best Medical Alert Devices for Active Seniors
Are you looking for a medical alert device that is elegant-looking and balances your independence and safety? Here are the best devices to choose from.